Akari Murata
Akari Murata publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Epidemiology, on topics such as Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Systemic Sclerosis and Related Diseases and Inflammatory Myopathies and Dermatomyositis.
- World rank
- #5,809,748 of 7,710,434 ranked researchers
- Rank in Japan
- #208,907 of 383,136
- Works
- 15
- Citations
- 156
- Citations per work
- 10.4
What does Akari Murata research?
Akari Murata's work is mostly in Medicine (77%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1276.8%
- Medicine1276.8%
- Everything else318.5%
- Life Sciences14.7%
- 1Pulmonary and Respiratory Medicine35% of their works
- 2Oncology14% of their works
- 3Epidemiology12% of their works
- 4Pathology and Forensic Medicine9% of their works
- 5Cardiology and Cardiovascular Medicine7% of their works
- 6Molecular Biology5% of their works
Research topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Systemic Sclerosis and Related Diseases
- Inflammatory Myopathies and Dermatomyositis
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Pleural and Pulmonary Diseases
- Occupational and environmental lung diseases
- Cancer Genomics and Diagnostics
Which keywords describe Akari Murata's research?
The keywords of their largest research topics: Fibrosis, Interstitial Lung Disease, Autoantibodies, Idiopathic Pulmonary Fibrosis, TGF-ß, Treatment, Pulmonary Involvement and Systemic Sclerosis.
- Cancer Genomics
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- EGFR Mutations
- ALK Inhibitors
- Inflammatory Myopathies
- Systemic Sclerosis
- Treatment
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Fibrosis
- Autoantibodies
- TGF-ß
- Pulmonary Involvement
- Dermatomyositis
- Targeted Therapy
- BAP1 mutations
- Empyema
- Malignant Pleural Mesothelioma
- Pleural Effusion
- Mutational Signatures
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Fibrosis112 topics
- Interstitial Lung Disease102 topics
- Autoantibodies72 topics
- Idiopathic Pulmonary Fibrosis71 topic
- TGF-ß71 topic
- Treatment72 topics
- Pulmonary Involvement41 topic
- Systemic Sclerosis41 topic
- Dermatomyositis31 topic
- Inflammatory Myopathies31 topic
- Targeted Therapy32 topics
- ALK Inhibitors21 topic
- BAP1 mutations21 topic
- EGFR Mutations21 topic
- Empyema21 topic
- Immune Checkpoint Blockade21 topic
- Malignant Pleural Mesothelioma21 topic
- PD-1 and PD-L121 topic
- Pleural Effusion21 topic
- Cancer Genomics11 topic
- Mutational Signatures11 topic
Where does Akari Murata work?
Akari Murata's main affiliation in the publication record is Kanazawa University, Japan.
How many publications and citations does Akari Murata have?
OpenAlex counts 15 works and 156 citations for Akari Murata, an h-index of 7, ranking #5,809,748 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Akari Murata. Posts are plain text and can be reported.